Actively Recruiting

Age: 18Years +
All Genders
NCT07396623

Validation of French PHQ-4 and PC-PTSD-5 Screening Scales

Led by Assistance Publique - Hôpitaux de Paris · Updated on 2026-02-09

90

Participants Needed

1

Research Sites

80 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Mental illness is a major public health issue. It affects one in five people, represents the largest expense for health insurance (14%), is the leading cause of years lived with disability, and suicide is the main cause of death among people aged 15 to 35. Depression affects 15 to 20% of individuals at some point in their lives. Trauma-related disorders affect 4.6% of people, including 1- 2% with post-traumatic stress disorder (PTSD). Screening for mental health problems in primary care is crucial. It enables doctors to provide early treatment, reduces the need for emergency care, and decreases both the number and duration of hospital stays. However, general practitioners and other non-mental health professionals often report lacking the time, training, and tools to conduct such screenings. Fortunately, brief and validated screening tools exist in English: The PHQ-4 (Patient Health Questionnaire-4) for anxiety and depression, and the PC-PTSD-5 (Primary Care PTSD Screen for DSM-5) for PTSD. So far, no French versions of these tools have been validated.

CONDITIONS

Official Title

Validation of French PHQ-4 and PC-PTSD-5 Screening Scales

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 218 years
  • Outpatient or hospitalized for any health-related reason
  • Oral and written proficiency in French
  • Patient informed and willing to participate in the study
  • Patient with health insurance coverage
Not Eligible

You will not qualify if you...

  • Individuals under legal protection measures (guardianship, conservatorship, or legal supervision)
  • Factors preventing obtaining non-opposition or conducting the research, such as limited French proficiency, hearing impairment, or significant cognitive disorders

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hôpital Avicenne

Bobigny, France, 93000

Actively Recruiting

Loading map...

Research Team

V

Vladimir ADRIEN, Doctor

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here